|
KMID : 0624620140470040215
|
|
BMB Reports
2014 Volume.47 No. 4 p.215 ~ p.220
|
|
|
Therapeutic effect of a TM4SF5-specific peptide vaccine against colon cancer in a mouse model
|
|
Kwon Sang-Hoon
Kim Young-Eun
Park Jeong-A
Kim Doo-Sik
Kwon Hyung-Joo
Lee Young-Hee
|
|
|
Abstract
|
|
|
|
Molecular-targeted therapy has gained attention because of its high efficacy and weak side effects. Previously, we confirmed that transmembrane 4 superfamily member 5 protein (TM4SF5) can serve as a molecular target to prevent or treat hepatocellular carcinoma (HCC). We recently extended the application of the peptide vaccine, composed of CpG-DNA, liposome complex, and TM4SF5 peptide, to prevent colon cancer in a mouse model. Here, we first implanted mice with mouse colon cancer cells and then checked therapeutic effects of the vaccine against tumor growth. Immunization with the peptide vaccine resulted in robust production of TM4SF5-specific antibodies, alleviated tumor growth, and reduced survival rate of the tumor-bearing mice. We also found that serum levels of VEGF were markedly reduced in the mice immunized with the peptide vaccine. Therefore, we suggest that the TM4SF5-specific peptide vaccine has a therapeutic effect against colon cancer in a mouse model.
|
|
|
KEYWORD
|
|
|
Animal model, Colon cancer, Peptide vaccine, Therapeutics, TM4SF5
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|
|